AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research Agenda

Daily-use HIV Prevention Approaches Didn’t Work for African Women in the VOICE Study

blog.aids.gov

According to findings of a major HIV prevention trial presented Monday, March 4, 2013 at the 20th Conference on Retroviruses and Opportunistic Infections (CROI), study participants who received daily oral pre-exposure prophylaxis (PrEP) did not experience any protection against HIV compared to those in the placebo arm, likely because very few were taking the study…

NIAID Advances Efforts to Restructure Clinical Trials Networks with Funding Announcements

NIAID wordle

Over the past year and a half, many of you followed the AIDS.gov blog post series Future Directions for NIAID HIV Research by Dr. Carl Dieffenbach, Director of the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID) at NIH. Last week, NIAID advanced those efforts by issuing several requests for applications (RFAs)…

New Announcement about PrEP from NIH

NIAID

The National Institutes of Health National Institute of Allergy and Infectious Diseases just made a significant announcement on pre-exposure prophylaxis (PrEP). I am proud to share this important update from the NIH with our blog readers. Learn more by reading this Q&A.

Advancing Pediatric, Maternal and Child Health

Future Directions for NIAID HIV Research

Co-authored by Edward Handelsman, M.D., Chief of NIAID’s Pediatric Medicine Branch within the Division of AIDS, and Lynne Mofenson, M.D., Chief of the Pediatric, Adolescent and Maternal AIDS Branch within the Eunice Kennedy Shriver National Institute of Child Health & Human Development. As a result of our continued dialogue with our collaborators and stakeholders, NIAID…

NIAID to Host Public Meeting on Future HIV/AIDS Research Networks

blog.aids.gov

The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH will host a public meeting on Tuesday, October 26, 2010, in Arlington, Va., to examine the future of the Institute’s HIV/AIDS clinical trial networks. Currently, NIAID supports six HIV/AIDS networks; the awards supporting those networks are set to expire in 2013 and…

Highlights from the 2010 Conference on Retroviral and Opportunistic Infections

Dr. Anthony Fauci

A week ago we blogged about ways to stay connected to the 17th Conference on Retroviral and Opportunistic Infections (CROI). Since then, the world’s premiere researchers and scientists have come together at the San Francisco Moscone Center to discuss advances and future directions in the prevention and treatment of HIV and AIDS. Throughout the conference…

Testing HIV Drugs as Prevention

Dr. Carl Dieffenbach, PhD

Last year, the U.S. Centers for Disease Control and Prevention (CDC) announced that the number of annual new HIV infections in the United States is actually 40% higher than previously estimated. This means that more than 56,000 Americans are infected with HIV every year despite public education efforts on how to avoid getting infected. Addressing…